HPV9 vaccine to be added to national immunisation schedules from January 2027
HPV9 will replace HPV2 for female students who have yet to start or complete their vaccination series under the Health Promotion Board's school-based programme.
From January 2027, Singapore will expand its national immunisation schedules to include the HPV9 vaccine. This vaccine, also known as Gardasil 9, will replace the current HPV2 vaccine for female students who have not yet started or completed their vaccination series through the Health Promotion Board's school-based programme. The Ministry of Health, Health Promotion Board, and Communicable Diseases Agency announced the addition of HPV9 to the National Childhood Immunisation Schedule, National Adult Immunisation Schedule, and Subsidised Vaccine List from January 1, 2027.
The HPV9 vaccine provides broader protection against cervical cancer, covering an additional 20% of cervical cancer-causing HPV types compared to HPV2. Unvaccinated females can start their vaccination series with either HPV2 or HPV9, with recommended dosages varying based on age. The new schedule includes full subsidies for eligible Singaporean children and means-tested subsidies for eligible Singaporean adults and permanent residents, with MediSave use also extended to HPV9 vaccination.
Written by urgent.news from Channel News Asia's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- HPV9 vaccine to be added to national immunisation schedules from January 2027 channelnewsasia.com